# CCR5-modified CD4+ T Cells for HIV Infection

> **NCT03666871** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** SB-728-T
- **BIOLOGICAL:** Expanded unmodified autologous CD4+ T cells

## Key facts

- **NCT ID:** NCT03666871
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-12
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-02-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03666871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03666871, "CCR5-modified CD4+ T Cells for HIV Infection". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03666871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*